Tekla Life Sciences Investors ( HQL) - Dividend Growth Rate (DGR)
HQL Dividend Growth Rate for past 3 years (DGR3)
Dividend history for stock HQL (Tekla Life Sciences Investors) including dividend growth rate predictions based on history.
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 4.250USD | 20.14% |
| 2035 | 3.934USD | 18.65% |
| 2034 | 3.643USD | 17.26% |
| 2033 | 3.372USD | 15.98% |
| 2032 | 3.122USD | 14.80% |
| 2031 | 2.890USD | 13.70% |
| 2030 | 2.676USD | 12.68% |
| 2029 | 2.477USD | 11.74% |
| 2028 | 2.294USD | 10.87% |
| 2027 | 2.123USD | 10.06% |
| 2026 | 1.966USD | 9.32% |
HQL Dividend Growth Rate for past 5 years (DGR5)
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 3.894USD | 18.45% |
| 2035 | 3.633USD | 17.22% |
| 2034 | 3.391USD | 16.07% |
| 2033 | 3.164USD | 15.00% |
| 2032 | 2.953USD | 13.99% |
| 2031 | 2.756USD | 13.06% |
| 2030 | 2.572USD | 12.19% |
| 2029 | 2.400USD | 11.37% |
| 2028 | 2.239USD | 10.61% |
| 2027 | 2.090USD | 9.90% |
| 2026 | 1.950USD | 9.24% |
HQL Dividend Growth Rate for past 10 years (DGR10)
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 1.956USD | 9.27% |
| 2035 | 1.943USD | 9.21% |
| 2034 | 1.931USD | 9.15% |
| 2033 | 1.918USD | 9.09% |
| 2032 | 1.906USD | 9.03% |
| 2031 | 1.893USD | 8.97% |
| 2030 | 1.881USD | 8.91% |
| 2029 | 1.868USD | 8.85% |
| 2028 | 1.856USD | 8.80% |
| 2027 | 1.844USD | 8.74% |
| 2026 | 1.832USD | 8.68% |
HQL
Price: $21.10
Dividend Yield: 10.25%
Forward Dividend Yield: 11.75%
Payout Ratio: 146.27%
Dividend Per Share: 2.48 USD
Earnings Per Share: 2.79 USD
P/E Ratio: 5.77
Exchange: NYQ
Sector: Financial Services
Industry: Asset Management
Country: United States
Volume: 93486
Market Capitalization: 605.1 million
Average Dividend Frequency: 4
Years Paying Dividends: 31
DGR3: 8.01%
DGR5: 7.16%
DGR10: 0.66%
DGR20: 22.46%